2抑制剂-话题@MedSci

#2抑制剂#

221篇内容 | 4052人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995497, encodeId=099e199549eed, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, objectType=article, longId=114676, objectId=4ab01146e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab01146e693, replyNumber=0, likeNumber=63, createdTime=2018-03-19, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab01146e693, moduleTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ab01146e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995485, encodeId=e73c1995485b2, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JAHA：钠葡萄糖协同转运蛋白2抑制剂对24小时动态血压有何影响？, objectType=article, longId=99266, objectId=797799266bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=797799266bf, replyNumber=0, likeNumber=62, createdTime=2017-08-18, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=797799266bf, moduleTitle=JAHA：钠葡萄糖协同转运蛋白2抑制剂对24小时动态血压有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=797799266bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995507, encodeId=30c7199550ed9, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, objectType=article, longId=124719, objectId=55c6124e19ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c6124e19ac, replyNumber=0, likeNumber=80, createdTime=2018-05-17, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c6124e19ac, moduleTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c6124e19ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995501, encodeId=f12419955011f, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabet Med：钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管的影响, objectType=article, longId=119272, objectId=d5fb1192e27a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5fb1192e27a, replyNumber=0, likeNumber=88, createdTime=2018-06-16, rootId=0, userName=liuquan, userId=28b7142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5fb1192e27a, moduleTitle=Diabet Med：钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5fb1192e27a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995492, encodeId=a13d1995492b8, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？, objectType=article, longId=104953, objectId=af4f10495358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4f10495358, replyNumber=0, likeNumber=56, createdTime=2018-03-29, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4f10495358, moduleTitle=J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4f10495358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995488, encodeId=9366199548808, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=SCI REP：SGLT2抑制剂对2型糖尿病患者尿路感染和生殖系感染的影响！, objectType=article, longId=100925, objectId=35501009257d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35501009257d, replyNumber=0, likeNumber=0, createdTime=2017-12-01, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35501009257d, moduleTitle=SCI REP：SGLT2抑制剂对2型糖尿病患者尿路感染和生殖系感染的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35501009257d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995487, encodeId=1f71199548e94, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JAHA：钠葡萄糖协同转运2抑制剂对2型糖尿病患者血压有何影响？, objectType=article, longId=99863, objectId=f2129986326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2129986326, replyNumber=0, likeNumber=60, createdTime=2017-11-03, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2129986326, moduleTitle=JAHA：钠葡萄糖协同转运2抑制剂对2型糖尿病患者血压有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2129986326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995486, encodeId=f4f7199548618, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Lancet：急性冠脉综合征临床显著出血：P2Y12抑制剂+利伐沙班vs阿司匹林, objectType=article, longId=99395, objectId=1a2d99395a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a2d99395a3, replyNumber=0, likeNumber=78, createdTime=2017-09-24, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a2d99395a3, moduleTitle=Lancet：急性冠脉综合征临床显著出血：P2Y12抑制剂+利伐沙班vs阿司匹林, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a2d99395a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995495, encodeId=56a4199549534, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多, objectType=article, longId=111182, objectId=d149111182b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d149111182b8, replyNumber=0, likeNumber=67, createdTime=2018-01-27, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d149111182b8, moduleTitle=Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d149111182b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995489, encodeId=f7891995489ed, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险, objectType=article, longId=101327, objectId=111310132efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=111310132efa, replyNumber=0, likeNumber=73, createdTime=2017-11-28, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=111310132efa, moduleTitle=NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=111310132efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995493, encodeId=15551995493f2, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？, objectType=article, longId=106282, objectId=af9e1062826b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9e1062826b, replyNumber=0, likeNumber=67, createdTime=2018-03-03, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9e1062826b, moduleTitle=Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9e1062826b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995491, encodeId=17671995491f4, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用, objectType=article, longId=102563, objectId=be2010256397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be2010256397, replyNumber=0, likeNumber=88, createdTime=2017-10-03, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be2010256397, moduleTitle=Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be2010256397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995490, encodeId=d4ce19954900f, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果, objectType=article, longId=101497, objectId=250110149ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250110149ec1, replyNumber=0, likeNumber=87, createdTime=2018-03-09, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250110149ec1, moduleTitle=Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250110149ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995484, encodeId=74661995484aa, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Circulation：SGLT-2抑制剂与其他降糖药对患者心脏衰竭和死亡风险的影响, objectType=article, longId=99260, objectId=9f869926077, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f869926077, replyNumber=0, likeNumber=71, createdTime=2018-03-10, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f869926077, moduleTitle=Circulation：SGLT-2抑制剂与其他降糖药对患者心脏衰竭和死亡风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f869926077)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995483, encodeId=fb78199548389, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=糖尿病患者福音！阿斯利康DPP4/SGLT2抑制剂组合疗法Qtern获欧盟批准, objectType=article, longId=73845, objectId=530de384583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=530de384583, replyNumber=0, likeNumber=60, createdTime=2017-05-20, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=530de384583, moduleTitle=糖尿病患者福音！阿斯利康DPP4/SGLT2抑制剂组合疗法Qtern获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=530de384583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995482, encodeId=99b5199548268, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=FDA专家组12:11支持SGLT2抑制剂Jardiance标签扩展, objectType=article, longId=72020, objectId=e2b6e2020ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2b6e2020ae, replyNumber=0, likeNumber=65, createdTime=2017-01-26, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2b6e2020ae, moduleTitle=FDA专家组12:11支持SGLT2抑制剂Jardiance标签扩展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2b6e2020ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995478, encodeId=8a4d19954e891, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=CDS 2015：MedSci专访纪立农教授：SGLT2抑制剂恩格列净降糖同时心血管获益明显, objectType=article, longId=60612, objectId=545f6061209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=545f6061209, replyNumber=0, likeNumber=60, createdTime=2016-04-01, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=545f6061209, moduleTitle=CDS 2015：MedSci专访纪立农教授：SGLT2抑制剂恩格列净降糖同时心血管获益明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=545f6061209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995479, encodeId=32d319954e98a, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Lancet Diabetes Endo：SGLT2抑制剂对2型糖尿病患者心血管健康的影响, objectType=article, longId=65071, objectId=efab650e1c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efab650e1c7, replyNumber=0, likeNumber=91, createdTime=2016-11-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efab650e1c7, moduleTitle=Lancet Diabetes Endo：SGLT2抑制剂对2型糖尿病患者心血管健康的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efab650e1c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995473, encodeId=49bf19954e396, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=NEJM：SGLT2抑制剂恩格列净降糖同时心血管获益明显(EMPA-REG OUTCOME研究), objectType=article, longId=56883, objectId=6ed9568838d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ed9568838d, replyNumber=0, likeNumber=63, createdTime=2015-10-11, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ed9568838d, moduleTitle=NEJM：SGLT2抑制剂恩格列净降糖同时心血管获益明显(EMPA-REG OUTCOME研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ed9568838d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995481, encodeId=cce519954814d, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Cancer Res：COX-2抑制剂塞来昔布可能具有抗癌作用, objectType=article, longId=69366, objectId=5df56936690, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df56936690, replyNumber=0, likeNumber=72, createdTime=2017-01-28, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df56936690, moduleTitle=Cancer Res：COX-2抑制剂塞来昔布可能具有抗癌作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df56936690)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2抑制剂

2020-05-29

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。

2018-03-19

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

JAHA：钠葡萄糖协同转运蛋白2抑制剂对24小时动态血压有何影响？

2017-08-18

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？

2018-05-17

liuquan (审核中...)

前往app查看评论内容

#2抑制剂#

Diabet Med：钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管的影响

2018-06-16

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？

2018-03-29

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

SCI REP：SGLT2抑制剂对2型糖尿病患者尿路感染和生殖系感染的影响！

2017-12-01

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

JAHA：钠葡萄糖协同转运2抑制剂对2型糖尿病患者血压有何影响？

2017-11-03

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Lancet：急性冠脉综合征临床显著出血：P2Y12抑制剂+利伐沙班vs阿司匹林

2017-09-24

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多

2018-01-27

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险

2017-11-28

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Cancer Immunol Res：COX-2抑制剂对抗癌治疗有帮助？

2018-03-03

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用

2017-10-03

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果

2018-03-09

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Circulation：SGLT-2抑制剂与其他降糖药对患者心脏衰竭和死亡风险的影响

2018-03-10

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

糖尿病患者福音！阿斯利康DPP4/SGLT2抑制剂组合疗法Qtern获欧盟批准

2017-05-20

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

FDA专家组12:11支持SGLT2抑制剂Jardiance标签扩展

2017-01-26

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

CDS 2015：MedSci专访纪立农教授：SGLT2抑制剂恩格列净降糖同时心血管获益明显

2016-04-01

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Lancet Diabetes Endo：SGLT2抑制剂对2型糖尿病患者心血管健康的影响

2016-11-22

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

NEJM：SGLT2抑制剂恩格列净降糖同时心血管获益明显(EMPA-REG OUTCOME研究)

2015-10-11

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Cancer Res：COX-2抑制剂塞来昔布可能具有抗癌作用

2017-01-28

科室
- - 订阅+
  - 更多科室
工具
服务